|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,279.10 INR | +0.40% |
|
+4.05% | +11.98% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Generic Pharmaceuticals | +0.40% | +4.05% | +11.98% | +12.51% | +282.11% | 6.72B |  | |  |
- Stock Market
- Stocks
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
